<DOC>
	<DOC>NCT01285973</DOC>
	<brief_summary>The aim of this prospective study is to assess the utility of treatment of leg ulcers using a skin substitute, Integra®, assessing the quality of wound skin healing and transcutaneous oxygen pressure in the distal region of the wound. This is a multi-centre study on 60 patients who have a lower limb ulcer.</brief_summary>
	<brief_title>Evaluation of Integra® Artificial Dermis for the Treatment of Leg Ulcers</brief_title>
	<detailed_description />
	<criteria>patient with a lower limb ulcer, regardless of origin (arterial, venous or mixed, diabetic foot ulcer) present for more than 6 months or large in size (&gt; 10 cm²) patients in whom the surgeon has recommended that an Integra® matrix be implanted (even if the patient is not taking part in the study) before the dermoepidermal graft to obtain a richly vascularised neodermis. not eligible for skin flap surgery, the patient or patient's representative has agreed to sign the information letter before any investigation required by the research. circumferential wound, wound infection immunosuppressed patient, known allergy to bovine collagen, bovine glycosaminoglycans or silicone, patients under legal guardianship, pregnant women patients whose health would compromise followup for at least 18 months, patients whose mental health would compromise completion of the selfevaluation questionnaires. wound located in an area not visible by the patient (as no selfassessment would be possible).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>